ROG.SW CHMP opinion: Thursday, July 23, 2026

Variation type II · Ocrevus · Update of section 4.8 of the SmPC to add COVID-19 and COVID-19 pneumonia as newly identified adverse drug reactions (ADRs) for Ocrevus. The Package Leaflet is updated accordingly. In addition, the MAH took the opportunity to update the list of local representatives in

Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.